Showing 5151-5160 of 21466 results for "".
- External Validation of Deep Learning for Barrett's Dysplasiahttps://reachmd.com/news/deep-learning-barretts-dysplasia/2487516/Key Takeaways External testing assessed classification across nondysplastic Barrett's esophagus, low-grade dysplasia, and high-grade dysplasia on whole slide images from three academic centers. Specificity reached 94.8% for high-grade dysplasia, while
- FDA Approves SKINVIVE by JUVÉDERM® for Treatment of Horizontal Neck Lineshttps://reachmd.com/news/fda-approves-skinvive-by-juvederm-for-treatment-of-horizontal-neck-lines/2487508/The US Food and Drug Administration (FDA) has approved SKINVIVE by JUVÉDERM® (Allergan Aesthetics, an AbbVie company) for the reduction of neck lines and improvement of neck appearance in adults aged 21 years and older, according to an announcement from the company. With the approval, SKIN
- Finerenone in Glomerular Disease-Associated CKDhttps://reachmd.com/news/finerenone-in-glomerular-disease-associated-ckd/2487494/Key Takeaways Participants with investigator-reported glomerular disease within a larger nondiabetic CKD trial received finerenone 10 mg or 20 mg once daily or matching placebo. Finerenone was associated with slower eGFR decline, 42% lower albuminuria
- Real-World Personalized SLIT Outcomes in Telemedicine Carehttps://reachmd.com/news/real-world-personalized-slit-outcomes-in-telemedicine-care/2487489/Key Takeaways The proportion reaching a 30-point or greater symptom improvement at least once increased from 28% at 12 months to 45% at 24 months. Medication use decreased over time, and more than 80% reported quality-of-life improvement across interva
- AI Fracture Detection on CT: Review Finds Moderate To Good Accuracyhttps://reachmd.com/news/ai-fracture-detection-on-ct-review-finds-moderate-to-good-accuracy/2487488/Key Takeaways Across unselected cohorts, stand-alone AI showed moderate sensitivity and good specificity for CT fracture detection overall. Sensitivity was higher in selected cohorts and internal datasets than in external datasets, and performance vari
- Vodobatinib Fails To Slow Early Parkinson Disease In Phase 2 Trialhttps://reachmd.com/news/vodobatinib-fails-to-slow-early-parkinson-disease-in-phase-2-trial/2487491/Key Takeaways Neither vodobatinib dose showed benefit over placebo on the week-40 MDS-UPDRS Part III primary endpoint. Several secondary measures also favored placebo, including shorter time to significant worsening in the high-dose group. Dis
- PORTEC-4a Trial Reports Molecular Profile Guided Adjuvant Treatmenthttps://reachmd.com/news/portec-4a-trial-reports-molecular-profile-guided-adjuvant-treatment/2487493/Key Takeaways Five-year vaginal recurrence was numerically higher with the molecular-profile strategy, although the prespecified non-inferiority criterion was met. Favorable profiles were assigned observation, intermediate profiles brachytherapy, and u
- Cabozantinib Triplet in Advanced RCC: Final COSMIC 313 Resultshttps://reachmd.com/news/cabozantinib-triplet-in-advanced-rcc-final-cosmic-313-results/2487490/Key Takeaways Longer progression-free survival with cabozantinib, nivolumab, and ipilimumab persisted at final follow-up, while overall survival remained comparable between groups. Objective response was higher with the triplet, but treatment-related t
- Ludient Launches in US With AI-Driven Approach to Clinical Skincarehttps://reachmd.com/news/ludient-launches-in-us-with-ai-driven-approach-to-clinical-skincare/2487480/Ludient, a clinical skincare brand developed by lululab, has officially launched in the United States, introducing an artificial intelligence (AI)-driven approach to skincare product development. According to the company, Ludient’s platform is powered by its proprietary luluTI™ technology,
- Telehealth Rehabilitation and Quality of Life After Mechanical Ventilationhttps://reachmd.com/news/telehealth-rehab-quality-life-mechanical-ventilation/2487478/Key Takeaways An integrated telehealth rehabilitation strategy was associated with higher quality-of-life utility at 90 days after discharge. Mortality, ventilation duration, days alive and free of hospital, and ordinal clinical status also moved in a